NO904235D0 - Forbedret cytotoksisk terapi. - Google Patents

Forbedret cytotoksisk terapi.

Info

Publication number
NO904235D0
NO904235D0 NO904235A NO904235A NO904235D0 NO 904235 D0 NO904235 D0 NO 904235D0 NO 904235 A NO904235 A NO 904235A NO 904235 A NO904235 A NO 904235A NO 904235 D0 NO904235 D0 NO 904235D0
Authority
NO
Norway
Prior art keywords
cytotoxic therapy
improved cytotoxic
improved
therapy
cytotoxic
Prior art date
Application number
NO904235A
Other languages
English (en)
Other versions
NO904235L (no
Inventor
M David Goldenberg
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/001209 external-priority patent/WO1989009061A1/en
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of NO904235D0 publication Critical patent/NO904235D0/no
Publication of NO904235L publication Critical patent/NO904235L/no

Links

NO90904235A 1988-03-29 1990-09-28 Forbedret cytotoksisk terapi. NO904235L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17449088A 1988-03-29 1988-03-29
PCT/US1989/001209 WO1989009061A1 (en) 1988-03-29 1989-03-28 Improved cytotoxic therapy

Publications (2)

Publication Number Publication Date
NO904235D0 true NO904235D0 (no) 1990-09-28
NO904235L NO904235L (no) 1990-11-12

Family

ID=26779512

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904235A NO904235L (no) 1988-03-29 1990-09-28 Forbedret cytotoksisk terapi.

Country Status (1)

Country Link
NO (1) NO904235L (no)

Also Published As

Publication number Publication date
NO904235L (no) 1990-11-12

Similar Documents

Publication Publication Date Title
ATE120194T1 (de) Therapeutische nuleoside.
FI903656A0 (fi) Terapeutiska kinuklidinfoereningar.
FI883757A0 (fi) Terapeutiska nukleosider.
FI906367A0 (fi) Terapeutiska nukleosider.
DE68917895D1 (de) Katheter.
DE68912814T2 (de) Spritzen.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
DE68911473D1 (de) Arzneimittelformulierungen.
DE68907325T2 (de) Massagegerät.
FI894688A (fi) Flytande oralt tagbart terapeutiskt system.
FI881651A (fi) Terapeutiska nukleosider.
NO882653D0 (no) Doseringsform.
DE68907177D1 (de) Dosierungsform.
FI904854A0 (fi) Terapeutiska nukleosider.
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
FI893897A (fi) Terapeutiska nukleosider.
FI881216A0 (fi) Terapeutiska nukleosider.
FI894321A0 (fi) Terapeutiska aemnen.
FI893366A0 (fi) 4-piperidylmetyl-2,3-dihydro-1h -isoindol- och 2,3,4,5-tetrahydro-1h-bensasepinderivat, deras framstaellning och terapeutiska anvaendning.
NO904235D0 (no) Forbedret cytotoksisk terapi.
FI883268A0 (fi) Engaongssugpaose foer patientsekret.
NO901574D0 (no) Terapeutiske midler.
NO901573L (no) Terapeutiske midler.
ES1004874Y (es) Vendaje terapeutico mejorado.
FI912852A0 (fi) Terapeutiska dekapeptider.